Skip to content
Clinical Trials – home
Karolinska Institutet
Sponsor

Karolinska Institutet

Sweden Nobels Vag 6, 171 65 Solna, Sweden

About the sponsor

Clinical research includes heart failure with reduced ejection fraction, severe chronic kidney disease, acute myocardial infarction, and left ventricular thrombosis, with additional interest in treatment strategies for acute ischaemic stroke.

  • Heart failure
  • Chronic kidney disease
  • Myocardial infarction
  • Stroke
  • Thromboembolic disease

Work in this area also extends to anticoagulation, biomarker-informed treatment selection, and cardiovascular complications after major cardiac events.

About Specializations

Karolinska Institutet runs clinical trials in conditions such as Breast cancer female, Abortion induced, Rhinitis allergic, Colorectal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

25 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Metformin Hydrochloride
  • Sponsor:Karolinska Institutet
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Karolinska Institutet
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Karolinska Institutet
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Letrozole
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Mannitol
  • Sponsor:Karolinska Institutet

Chronic kidney disease

Not yet recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Altizide
  • Sponsor:Karolinska Institutet

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).